Follow-The-Filings

Security · featured owners

CRL Charles Riv Labs Intl Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 4 Owners
  • Max 3.4%
  • $854M
  • 1 new 2 add 1 reduce 1 exit

CRL (Charles Riv Labs Intl Inc.) is held in 4 featured 13F books as of 2026 Q2. John Rogers - Ariel Investments is the largest tracked holder by portfolio weight (3.4%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 3.4% (John Rogers - Ariel Investments) · not free-float ownership

  1. John Rogers add 3.4%
  2. Bill Nygren / Oakmark add 0.67%
  3. David Witzke new 0.36%
  4. Murray Stahl reduce 0.02%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Bill Nygren / Oakmark - Harris Associates L P 2026 Q2 0.67% Add +4.1% 2,241,144 $508M history
John Rogers - Ariel Investments 2026 Q2 3.4% Add +4.3% 1,506,185 $342M history
David Witzke - Avidity Partners Management 2026 Q2 0.36% New 0.36% 10,000 $2M history
Murray Stahl - Horizon Kinetics Asset Management 2026 Q2 0.02% Reduce −41.7% 7,103 $2M history
Lee Ainslie - Maverick Capital exited 2026 Q2 last 2026 Q1 0.02% Exit −0.02% 8,178 $1M history

4 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 3 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,5.07,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 14 rows shown

Filed Form Detail Links
4 Period Aug 25, 2026 Filing Doc
4 Period Aug 18, 2026 Filing Doc
4 Period Aug 19, 2026 · 2 forms Filing Doc
4 Period Aug 11, 2026 · 2 forms Filing Doc
4 Period Aug 10, 2026 · 2 forms Filing Doc
4 Period Aug 6, 2026 · 2 forms Filing Doc
4 Period Aug 5, 2026 Filing Doc
4 Period Jun 29, 2026 Filing Doc
4 Period Jun 5, 2026 · 3 forms Filing Doc
4 Period Jun 2, 2026 Filing Doc
4 Period May 29, 2026 · 2 forms Filing Doc
4 Period May 30, 2026 Filing Doc
4 Period May 29, 2026 · 5 forms Filing Doc
4 Period May 26, 2026 Filing Doc

Updated 6 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $4.13B $4.05B $4.02B
Net income $474.62M $22.2M -$144.34M
Net margin * 11.5% 0.5% -3.6%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $1.61B $1.4B $1.45B
Total non-current assets * $6.59B $6.13B $5.69B
Total assets $8.2B $7.53B $7.14B
Total current liabilities $1.06B $0.994B $1.12B
Total non-current liabilities * $3.48B $3.03B $2.8B
Total equity $3.6B $3.46B $3.16B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $683.9M $734.58M $737.65M
Cash from investing -$563.16M -$245.09M -$209.32M
Cash from financing -$85.52M -$550.93M -$536.73M
Net change in cash $43.27M -$78.91M $10.43M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders